Legal efforts to address the ongoing opioid crisis have been ramping up across the nation. Most notably, a federal court is set to hear a massive case against a number of big players in the pharmaceutical industry.
An issue in the hearing will be determining to what extent pharmaceutical companies can be held responsible for pushing and selling opioids. Additionally, the federal court is also set to consider any penalties these companies may face.
As this potentially landmark federal case draws nearer, several of the defendants requested that the judge set to hear the case recuse himself. Now, that judge has indicated that he will not remove himself. Instead, the case will proceed as planned.
A Landmark Case Against Big Pharma
The case in question is scheduled to begin next month, on October 21. Importantly, this will be the first time a federal court has heard a case from government players against pharmaceutical companies involved in the opioid market.
Plaintiffs in the case are going after the companies that make, distribute, and sell opioids. Specifically, the primary argument is that these companies should be held responsible, at least in part, for the deaths and health problems caused by opioids.